Fifty Years

Fifty Years is a venture capital firm founded in 2016 and located in San Francisco, California. The firm focuses on supporting entrepreneurs who leverage technology to address significant global challenges. Fifty Years primarily invests in companies within the technology sector in North America and Europe. Its investment strategy emphasizes backing ventures that have the potential to achieve substantial profitability while contributing to the attainment of the Sustainable Development Goals. By prioritizing innovative solutions and impactful business models, Fifty Years aims to foster a positive change in society through its portfolio companies.

Seth Bannon

Founding Partner

David Phoenix

Partner

Alex Teng

Partner

Shuo Yang

Principal

170 past transactions

Deepcell

Venture Round in 2025
Deepcell, Inc. is a biotechnology company based in Mountain View, California, that specializes in providing advanced diagnostic solutions through its innovative microfluidic imaging platform. Founded in 2015, the company focuses on delivering non-invasive tests with diagnostic-level accuracy, enabling researchers and clinicians to gain insights at the single-cell level. Deepcell's technology employs artificial intelligence to analyze and classify cells based on their morphological features, isolating viable cells for various applications in translational research, diagnostic testing, and therapeutics. By utilizing ordinary blood samples, Deepcell enhances the understanding of genetic health without the need for invasive procedures, thereby improving the diagnosis and treatment of diseases.

Gridware

Series A in 2025
Gridware specializes in advanced grid monitoring solutions aimed at enhancing the safety and reliability of electrical infrastructure. The company develops a sophisticated sensing system equipped with high-precision sensor arrays and artificial intelligence to continuously analyze the electrical and mechanical behavior of grid assets. This technology detects and predicts faults by monitoring the ambient environment around power poles, allowing utilities to identify potential issues before they escalate into serious problems. By facilitating timely repairs and enabling rapid responses to environmental anomalies, Gridware's solutions help mitigate risks such as wildfires and power outages. Headquartered in the Bay Area of California, Gridware is a privately held company supported by prominent climate-tech investors.

Aalo Atomics

Series A in 2024
Aalo Atomics is a clean energy company focused on the development and commercialization of small nuclear fission reactors. These compact reactors, designed for factory manufacturing, are capable of generating clean energy suitable for various applications, ranging from powering data centers to supplying energy for large cities. Aalo Atomics aims to make energy production more affordable while ensuring safety and sustainability. By harnessing nuclear energy, the company seeks to empower individuals and communities to reduce their power consumption and contribute to a cleaner energy future.

Waypoint Bio

Seed Round in 2024
Waypoint Bio is a company focused on advancing cell therapy to treat solid tumors in cancer patients. It has developed a novel platform that integrates spatial multi-omics, utilizing proprietary methodologies enhanced by artificial intelligence and machine learning. This innovative approach facilitates the design of effective and safe cell therapies through pooled screening techniques. By optimizing the application of cell therapy, Waypoint Bio aims to improve treatment outcomes for patients battling solid tumors.

BillionToOne

Series D in 2024
BillionToOne Inc. is a precision diagnostics company based in Menlo Park, California, that specializes in molecular testing for prenatal and oncology applications. Established in 2016, the company has developed a patented molecular counter platform capable of detecting and quantifying DNA molecules at an extraordinarily precise level. BillionToOne's flagship product, UNITY, is a noninvasive prenatal screening test that analyzes fetal cell-free DNA from a simple blood sample taken from the mother, allowing for the detection of single-gene disorders such as cystic fibrosis, spinal muscular atrophy, and beta-thalassemia. This innovative approach aims to replace more invasive procedures like amniocentesis, providing a safer and more affordable alternative for expecting mothers, particularly in developing countries. Additionally, the company is focused on oncology, offering tests that can accurately identify actionable mutations and assess tumor burden through blood samples.

The Bot Company

Seed Round in 2024
The Bot Company a household robot startup.

Nabla Bio

Series A in 2024
Nabla Bio operates an autoreverse platform that facilitates the rapid discovery of novel protein variants with unique properties. By leveraging insights gained from billions of natural proteins, the company engineers these enhanced proteins for both medical and industrial applications. Through extensive experimentation, Nabla Bio develops new medicines and improves nutritional products, allowing clients to conduct complex measurements of protein function and implement innovative solutions in various fields.

Varda

Series B in 2024
Varda Space Industries, Inc. is a space manufacturing startup based in San Francisco, California, founded in 2020 by Delian Asparouhov and Trae Stephens. The company specializes in creating products in space that are intended for terrestrial applications, leveraging the unique advantages of low gravity. Varda aims to establish an infrastructure for harvesting materials from asteroids, enabling the production of new products in space. This approach not only facilitates the manufacturing of innovative goods but also promotes sustainability by reducing reliance on the destructive extraction of Earth's resources.

Cosmic Aerospace

Seed Round in 2024
Cosmic Aerospace is an innovative aerospace technology company focused on advancing sustainable aviation through the development of ultra-efficient all-electric passenger aircraft. The company aims to create fully electric planes characterized by improved propulsion systems and unique airframe designs, which are intended to significantly reduce air pollution associated with regional flights. By prioritizing energy efficiency, Cosmic Aerospace seeks to facilitate a transition to more sustainable air travel, ultimately making aviation more environmentally friendly and accessible.

Planet A Foods

Series A in 2024
Planet A Foods is a company focused on producing cocoa-free chocolate made from natural ingredients. By utilizing traditional fermentation methods, the company aims to provide a sustainable alternative to traditional chocolate, allowing consumers to enjoy their chocolate cravings without the negative impacts associated with cocoa production. Planet A Foods emphasizes local food production with minimal environmental impact, striving to reduce carbon emissions and promote sustainable practices in the food industry.

Faction

Seed Round in 2023
Faction develops software and services for driverless electric vehicles. Faction's supervised autonomous vehicle solutions include remote human TeleAssist® supervision, so we’re not gated by waiting for 100% autonomous technology. Initially, Faction is focusing on micro delivery for last mile logistics and vehicle-on-demand, where you can summon a vehicle and drive it yourself. The company has active customer programs in operation on public roads.

Elicit

Seed Round in 2023
Elicit is an artificial intelligence research assistant that uses language models to help users automate research workflows. This research assistant finds relevant papers without a perfect keyword match, summarizes takeaways from the papers, and extracts key information from the papers.

BIOS

Series A in 2023
BIOS Health is a pioneering company focused on developing neural digital therapies by leveraging data from the human nervous system. By identifying neural biomarkers that correlate nerve activity to specific medical conditions, BIOS aims to revolutionize precision medicine. Their research offers the potential for innovative treatments for a range of chronic diseases, including hypertension, diabetes, and neurodegenerative disorders such as Parkinson's and Alzheimer's. Co-founded by experts from Cambridge University, the team includes professionals from diverse fields such as neuroscience, machine learning, and biotechnology. Additionally, BIOS is working on prosthetic connectors that standardize connections between bionic devices and neural systems, facilitating neural control and feedback for amputees. This dual approach positions BIOS at the forefront of improving the quality of life for individuals with chronic conditions and those requiring prosthetic solutions.

Gridware

Seed Round in 2023
Gridware specializes in advanced grid monitoring solutions aimed at enhancing the safety and reliability of electrical infrastructure. The company develops a sophisticated sensing system equipped with high-precision sensor arrays and artificial intelligence to continuously analyze the electrical and mechanical behavior of grid assets. This technology detects and predicts faults by monitoring the ambient environment around power poles, allowing utilities to identify potential issues before they escalate into serious problems. By facilitating timely repairs and enabling rapid responses to environmental anomalies, Gridware's solutions help mitigate risks such as wildfires and power outages. Headquartered in the Bay Area of California, Gridware is a privately held company supported by prominent climate-tech investors.

Tangible

Seed Round in 2023
Tangible is a climate technology company focused on building sustainable materials that are not harmful to the environment. Tangible is a unified software platform that catalyzes the adoption of sustainable building materials by allowing real estate developers, architects, and contractors to seamlessly identify, manage, and report on products that meet their carbon, environmental, and social goals. Founded in 2021 by Nicole Granath and Anneli Tostar, Tangible is headquartered in San Francisco, California, United States.

MultiOmic Health

Seed Round in 2023
MultiOmic Health is an AI-driven start-up specializing in drug discovery for metabolic syndrome-related diseases. The company collaborates with selected healthcare providers to collect and analyze de-identified patient data and bio-samples. Its MOHSAIC® platform integrates multi-omics analysis with computational systems biology modeling and targeted laboratory experiments to develop novel precision therapeutic concepts. These concepts are then commercialized through partnerships with established biopharma companies, facilitating the creation of new therapeutic and diagnostic research and development programs. By focusing on precision medicine, MultiOmic Health aims to improve treatment options for patients suffering from metabolic syndrome.

Noya

Series A in 2023
Noya is focused on addressing climate change by retrofitting existing industrial equipment to capture carbon dioxide from the atmosphere. The company's innovative technology utilizes a non-toxic chemical blend that is added to the cooling towers of various industries without requiring any structural modifications. This approach allows for effective CO2 capture while enabling businesses to contribute to environmental sustainability. By selling the captured carbon dioxide to companies that utilize it as a raw material, Noya facilitates a practical and scalable solution for reducing carbon emissions and promoting a transition towards a carbon-negative future.

Aalo Atomics

Seed Round in 2023
Aalo Atomics is a clean energy company focused on the development and commercialization of small nuclear fission reactors. These compact reactors, designed for factory manufacturing, are capable of generating clean energy suitable for various applications, ranging from powering data centers to supplying energy for large cities. Aalo Atomics aims to make energy production more affordable while ensuring safety and sustainability. By harnessing nuclear energy, the company seeks to empower individuals and communities to reduce their power consumption and contribute to a cleaner energy future.

Mindset Health

Series A in 2023
Mindset Health is a digital therapeutics company based in Melbourne, Victoria, founded in 2018 by Alex Naoumidis. The company focuses on helping individuals manage chronic health issues, particularly irritable bowel syndrome, anxiety, and chronic pain, through app-based hypnotherapy. Its platform provides treatment without necessitating dietary changes, enhancing sleep quality, and alleviating anxiety and stress. Mindset Health aims to offer a rapid, cost-effective, nonaddictive, and safe alternative for individuals seeking relief from these conditions, thereby improving overall well-being and quality of life.

Journey Clinical

Series A in 2023
Journey Clinical is a platform that provides services to member psychotherapy practices that are independently owned and operated, and in no way owns, directs, or controls the mental healthcare clinicians providing care.

Farcast

Venture Round in 2022
We build advanced satcom terminals

BillionToOne

Series C in 2022
BillionToOne Inc. is a precision diagnostics company based in Menlo Park, California, that specializes in molecular testing for prenatal and oncology applications. Established in 2016, the company has developed a patented molecular counter platform capable of detecting and quantifying DNA molecules at an extraordinarily precise level. BillionToOne's flagship product, UNITY, is a noninvasive prenatal screening test that analyzes fetal cell-free DNA from a simple blood sample taken from the mother, allowing for the detection of single-gene disorders such as cystic fibrosis, spinal muscular atrophy, and beta-thalassemia. This innovative approach aims to replace more invasive procedures like amniocentesis, providing a safer and more affordable alternative for expecting mothers, particularly in developing countries. Additionally, the company is focused on oncology, offering tests that can accurately identify actionable mutations and assess tumor burden through blood samples.

Solugen

Series D in 2022
Solugen, Inc. is a specialty chemicals company based in Houston, Texas, that focuses on producing industrial chemicals through industrial biotechnology and green chemistry. Founded in 2016, Solugen develops a range of environmentally friendly products, including BioPeroxide, a carbon-negative hydrogen peroxide, and BioChelate, a biodegradable chelant. The company also offers ScavSol, a multivalent metal sequestrant for energy applications; ScaleSol, an alternative to phosphonates for scale control; and CorrSol, a corrosion and fouling control product. By utilizing fermentation and enzymatic technology to convert plant sugars into chemicals, Solugen aims to replace petroleum-based products with plant-derived alternatives. Its innovative solutions are designed to benefit various industries, including agriculture, cleaning, energy, and water, while also addressing critical issues such as clean water, sustainable materials, and healthier personal care products.

Molten Industries

Seed Round in 2022
Molten Industries focuses on developing clean technology aimed at decarbonizing the hydrogen market. The company provides a cost-effective and environmentally friendly method for hydrogen production, which allows chemical and heavy industries to significantly reduce their carbon emissions. Through its innovative solutions, Molten Industries contributes to the transition towards sustainable energy practices.

Harmonic Discovery

Seed Round in 2022
Harmonic Discovery operates as a pharmaceutical company that develops a platform that combines computing and experimentation.

Arpeggio Bio

Series A in 2022
Arpeggio Biosciences leverages state of the art sequencing approaches coupled with powerful machine learning to uncover novel insights into a compound's biological mechanism of action. The company is diverse set of molecular biologists, computer scientists, and biotechnology enthusiasts passionate about understanding where, why, and how therapeutics work.

Persephone Biosciences

Seed Round in 2022
Persephone Biosciences develops healthcare technology designed to focus on microbial therapeutics for immuno-oncology applications. The company's technology uses artificial intelligence and omics techniques on multiple cancer patient gut microbiome and blood samples to identify microbes needed for normal immune function for population-scale patient data analytics, enabling lab researchers to design microbial drugs that prevent and fight cancer. Persephone Biosciences was founded in 2017 and is based in San Diego, California.

resistanceBio

Seed Round in 2022
Solving cancer resistance.

Manifold Bio

Series A in 2022
Manifold Bio is a biotechnology company that features a platform that enables multiplexed quantitation of protein therapeutic designs, generating unprecedented data throughout the drug development process to unlock measurement-driven design. The company is building a protein barcoding platform to bring the power of multiplexed measurement to the development of protein therapeutics. It was founded in 2020 and headquartered in Boston, Massachusetts.

LatchBio

Series A in 2022
LatchBio is a company that specializes in developing a bioinformatics platform aimed at supporting cell and gene therapy startups. Established in 2021 by Alfredo Andere, Kyle Giffin, and Kenny Workman, LatchBio provides an open-source machine learning and cloud infrastructure tailored for the biotech sector. Its platform modernizes the computing capabilities available to biotech labs by offering custom workflows, pipelines, and machine learning models that can be utilized across various scales. This infrastructure enables scientists to efficiently create bioinformatic queries without requiring extensive command-line knowledge or dealing with complex setups. By streamlining data integration and processing, LatchBio helps biotech companies accelerate therapeutic discovery and reduce engineering costs.

Boundary Layer Technologies

Seed Round in 2022
Boundary Layer Technologies is a startup that builds high-speed container ships using hydrofoil technology. It was founded in 2018.

Octant Bio

Series B in 2022
Octant Bio is a biotechnology company focused on developing synthetic technology aimed at enhancing health and treating diseases. The company employs a platform that integrates synthetic biology, genome engineering, next-generation sequencing, and computational tools to measure the activity of thousands of receptor pathways in human cells. This advanced technology allows scientists to utilize machine learning techniques to engineer small molecules capable of interacting with multiple receptors, thereby creating new possibilities for the treatment of complex diseases.

Ansa Biotechnologies

Series A in 2022
Ansa Biotechnologies is manufactured via a chemical method that has remained essentially unchanged for 35 years and has approached a plateau. Ansa Biotechnologies is developing a novel DNA synthesis technology based on enzymes that will be more fast, accurate, and clean than existing methods. The technique promises to dramatically accelerate innovation in biological research and engineering.

BillionToOne

Series C in 2022
BillionToOne Inc. is a precision diagnostics company based in Menlo Park, California, that specializes in molecular testing for prenatal and oncology applications. Established in 2016, the company has developed a patented molecular counter platform capable of detecting and quantifying DNA molecules at an extraordinarily precise level. BillionToOne's flagship product, UNITY, is a noninvasive prenatal screening test that analyzes fetal cell-free DNA from a simple blood sample taken from the mother, allowing for the detection of single-gene disorders such as cystic fibrosis, spinal muscular atrophy, and beta-thalassemia. This innovative approach aims to replace more invasive procedures like amniocentesis, providing a safer and more affordable alternative for expecting mothers, particularly in developing countries. Additionally, the company is focused on oncology, offering tests that can accurately identify actionable mutations and assess tumor burden through blood samples.

Antora Energy

Series A in 2022
Antora Energy specializes in providing zero-carbon industrial heat and power solutions for heavy industries, aiming to replace fossil fuels with cleaner alternatives. The company has developed innovative thermal batteries that utilize excess electricity generated from solar and wind sources. These batteries store thermal energy by heating blocks of carbon, which can then be used to produce reliable power and heat. By integrating renewable resources into the electricity grid, Antora enables industries to achieve sustainable and dependable energy solutions while significantly reducing carbon emissions.

Zero Acre Farms

Series A in 2022
Zero Acre Farms is a food company focused on eliminating the reliance on harmful vegetable oils in the food industry. It offers a sustainable alternative produced through fermentation technology, utilizing microorganisms to create oils and fats that contain significantly lower levels of unhealthy fats associated with inflammation and disease. This innovative approach aims to promote healthier dietary options for consumers while addressing the environmental concerns linked to traditional oil production.

MultiOmic Health

Seed Round in 2022
MultiOmic Health is an AI-driven start-up specializing in drug discovery for metabolic syndrome-related diseases. The company collaborates with selected healthcare providers to collect and analyze de-identified patient data and bio-samples. Its MOHSAIC® platform integrates multi-omics analysis with computational systems biology modeling and targeted laboratory experiments to develop novel precision therapeutic concepts. These concepts are then commercialized through partnerships with established biopharma companies, facilitating the creation of new therapeutic and diagnostic research and development programs. By focusing on precision medicine, MultiOmic Health aims to improve treatment options for patients suffering from metabolic syndrome.

Athelas

Venture Round in 2022
Athelas, Inc. is a healthcare company based in Mountain View, California, that specializes in developing and manufacturing in-home blood analysis devices aimed at diagnosing infections, inflammations, and malignancies. Founded in 2002, Athelas has created a portable optical unit that analyzes blood samples from a single drop, providing diagnostic reports to monitor the immune system. The company's FDA-cleared device is designed to help chronically ill patients manage their health at home, offering additional monitoring for blood pressure, weight, glucose levels, and medication adherence. This technology enables patients to monitor their immunity and assists healthcare providers in the early detection of conditions such as leukemia and other inflammatory diseases. Athelas operates as a subsidiary of MerLion Pharmaceuticals Pte. Ltd.

64x Bio

Series A in 2022
64x Bio develops a platform aimed at accelerating the discovery and optimization of mammalian cell lines for biomanufacturing and therapeutics. The company employs a high-throughput discovery and screening approach combined with an integrated computational design loop to create genetically engineered cell lines tailored for the production of viral vectors. This focus is particularly relevant for cell and gene therapies, as it enhances the efficiency of viral vector production. By providing purpose-built cell lines, 64x Bio enables pharmaceutical and biotechnology companies to improve their manufacturing capacity and reduce costs, ultimately facilitating the timely delivery of innovative therapies to patients.

HealthLeap

Pre Seed Round in 2022
HealthLeap aims to enhance global health by addressing disease-related malnutrition, a critical issue that significantly impacts patient outcomes. The company has developed an AI-based clinical assistant designed for healthcare professionals, which facilitates better diagnosis and treatment of malnutrition, often referred to as the "silent killer." This condition affects 30-50% of all hospital patients and is linked to a three to five times increase in mortality during hospital stays, yet only a small percentage are accurately diagnosed. HealthLeap's tool provides automated medical calculations and data-driven recommendations, enabling clinicians to optimize treatment quality, improve clinical outcomes, and reduce healthcare costs.

Tangible

Pre Seed Round in 2022
Tangible is a climate technology company focused on building sustainable materials that are not harmful to the environment. Tangible is a unified software platform that catalyzes the adoption of sustainable building materials by allowing real estate developers, architects, and contractors to seamlessly identify, manage, and report on products that meet their carbon, environmental, and social goals. Founded in 2021 by Nicole Granath and Anneli Tostar, Tangible is headquartered in San Francisco, California, United States.

InVivo AI

Seed Round in 2021
InVivo AI, founded in 2017 and based in Montreal, Canada, specializes in utilizing artificial intelligence to enhance pharmaceutical research and development, particularly in the area of preclinical toxicology. The company aims to streamline the drug discovery process by implementing advanced AI methods for molecular representation and de novo design, which allows for the creation of novel chemical compounds that can address complex biological challenges. Through its innovative platform, InVivo AI is positioned to significantly improve the efficiency and effectiveness of drug design, paving the way for breakthroughs in pharmaceutical science.

Nabla Bio

Seed Round in 2021
Nabla Bio operates an autoreverse platform that facilitates the rapid discovery of novel protein variants with unique properties. By leveraging insights gained from billions of natural proteins, the company engineers these enhanced proteins for both medical and industrial applications. Through extensive experimentation, Nabla Bio develops new medicines and improves nutritional products, allowing clients to conduct complex measurements of protein function and implement innovative solutions in various fields.

Planet A Foods

Seed Round in 2021
Planet A Foods is a company focused on producing cocoa-free chocolate made from natural ingredients. By utilizing traditional fermentation methods, the company aims to provide a sustainable alternative to traditional chocolate, allowing consumers to enjoy their chocolate cravings without the negative impacts associated with cocoa production. Planet A Foods emphasizes local food production with minimal environmental impact, striving to reduce carbon emissions and promote sustainable practices in the food industry.

Superdao

Pre Seed Round in 2021
Superdao is a platform designed to support the management and growth of decentralized autonomous organizations (DAOs) in the Web3 space. It offers tools for wallet analytics that provide organizations with insights into their dapp users, NFT and token holders, DAO voters, and quest participants. The platform features a hybrid governance system that facilitates collaborative management of decentralized application ventures, enabling users to create and customize intelligent contracts with ease. Additionally, Superdao includes a built-in member directory, treasury dashboard, and contributor management tools, which enhance decision-making and governance for DAOs. Organizations can leverage filter and export tools to build targeted lists and gain competitive insights from a database of audiences from numerous top Web3 projects.

World

Venture Round in 2021
World is a company that connects users through a privacy-focused network designed for secure digital asset management. It offers a digital currency platform that emphasizes both privacy and transparency using a permissionless blockchain. The World App enables users to securely store their World ID, manage digital assets, and access various Mini Apps, promoting global connectivity and trust. Additionally, World provides an iris-scanning device that enhances digital identity security by storing biometric information, which helps discourage spammers from creating multiple accounts. This combination of secure identity management and digital currency aims to facilitate a reliable and user-friendly digital environment.

LatchBio

Seed Round in 2021
LatchBio is a company that specializes in developing a bioinformatics platform aimed at supporting cell and gene therapy startups. Established in 2021 by Alfredo Andere, Kyle Giffin, and Kenny Workman, LatchBio provides an open-source machine learning and cloud infrastructure tailored for the biotech sector. Its platform modernizes the computing capabilities available to biotech labs by offering custom workflows, pipelines, and machine learning models that can be utilized across various scales. This infrastructure enables scientists to efficiently create bioinformatic queries without requiring extensive command-line knowledge or dealing with complex setups. By streamlining data integration and processing, LatchBio helps biotech companies accelerate therapeutic discovery and reduce engineering costs.

Journey Clinical

Seed Round in 2021
Journey Clinical is a platform that provides services to member psychotherapy practices that are independently owned and operated, and in no way owns, directs, or controls the mental healthcare clinicians providing care.

unspun

Series A in 2021
Unspun, Inc., founded in 2015 and based in San Francisco, California, specializes in the development of a platform that creates customized jeans using advanced body scanning technology, fit algorithms, and additive manufacturing. The company aims to address environmental concerns by reducing global carbon emissions through automated and localized manufacturing processes. Unspun’s innovative approach not only eliminates pattern-cutting waste and unsold inventory but also allows for the production of jeans in under ten minutes in a zero-waste manner. Their technology is showcased through the unspun.io platform, which provides digital customization solutions for various apparel brands. With a mission to make fashion more sustainable, Unspun is positioned at the intersection of robotics and digital apparel, striving to transform the industry with its unique approach to on-demand manufacturing.

Solugen

Series C in 2021
Solugen, Inc. is a specialty chemicals company based in Houston, Texas, that focuses on producing industrial chemicals through industrial biotechnology and green chemistry. Founded in 2016, Solugen develops a range of environmentally friendly products, including BioPeroxide, a carbon-negative hydrogen peroxide, and BioChelate, a biodegradable chelant. The company also offers ScavSol, a multivalent metal sequestrant for energy applications; ScaleSol, an alternative to phosphonates for scale control; and CorrSol, a corrosion and fouling control product. By utilizing fermentation and enzymatic technology to convert plant sugars into chemicals, Solugen aims to replace petroleum-based products with plant-derived alternatives. Its innovative solutions are designed to benefit various industries, including agriculture, cleaning, energy, and water, while also addressing critical issues such as clean water, sustainable materials, and healthier personal care products.

Nabla Bio

Pre Seed Round in 2021
Nabla Bio operates an autoreverse platform that facilitates the rapid discovery of novel protein variants with unique properties. By leveraging insights gained from billions of natural proteins, the company engineers these enhanced proteins for both medical and industrial applications. Through extensive experimentation, Nabla Bio develops new medicines and improves nutritional products, allowing clients to conduct complex measurements of protein function and implement innovative solutions in various fields.

Talus Bio

Pre Seed Round in 2021
Talus Bio is a biotech startup focused on drug discovery, particularly in the development of therapies targeting gene regulators for cancer treatment. The company utilizes a data-enabled platform that combines functional proteomics, automated biology, and machine learning to address the challenges associated with cancer transcription factors. Its proprietary MARMOT platform employs advanced techniques such as AI, quantitative proteomics, synthetic chemistry, and computational biology to design and analyze small-molecule drugs and proteins. This innovative approach aims to enhance drug development processes in the oncology sector, facilitating advancements in gene regulation and contributing to more effective cancer therapies.

Earth AI

Seed Round in 2021
Earth AI is a predictive explorer and driller specializing in critical minerals. The company operates as a vertically integrated mineral exploration firm, utilizing artificial intelligence to enhance mineral targeting. By predicting the locations of metallic ore bodies, Earth AI focuses on metals such as copper, lead, zinc, nickel, cobalt, vanadium, and rare earth elements. This innovative approach aims to improve the success rates of mineral discoveries while simultaneously reducing operational risks and costs for mining explorers.

Talus Bio

Seed Round in 2021
Talus Bio is a biotech startup focused on drug discovery, particularly in the development of therapies targeting gene regulators for cancer treatment. The company utilizes a data-enabled platform that combines functional proteomics, automated biology, and machine learning to address the challenges associated with cancer transcription factors. Its proprietary MARMOT platform employs advanced techniques such as AI, quantitative proteomics, synthetic chemistry, and computational biology to design and analyze small-molecule drugs and proteins. This innovative approach aims to enhance drug development processes in the oncology sector, facilitating advancements in gene regulation and contributing to more effective cancer therapies.

Nobell Foods

Series B in 2021
Nobell Foods uses plants to create innovative animal-based food substitutes.

Varda

Series A in 2021
Varda Space Industries, Inc. is a space manufacturing startup based in San Francisco, California, founded in 2020 by Delian Asparouhov and Trae Stephens. The company specializes in creating products in space that are intended for terrestrial applications, leveraging the unique advantages of low gravity. Varda aims to establish an infrastructure for harvesting materials from asteroids, enabling the production of new products in space. This approach not only facilitates the manufacturing of innovative goods but also promotes sustainability by reducing reliance on the destructive extraction of Earth's resources.

Atom Computing

Series A in 2021
Atom Computing builds truly scalable quantum computers out of individual atoms. The company's quantum computers use quantum mechanical properties of atoms to process information and solve problems beyond the reach of traditional computers, including drug design, computational chemistry, and more. Atom Computing was founded in 2018 and based in Berkeley, California.

Meati

Series B in 2021
Meati Foods is a Boulder, Colorado-based company specializing in the production and sale of fungi-based meat alternatives. Founded in 2016, the company aims to provide sustainable and nutritious plant-based options that serve as an alternative to traditional meat products. Meati Foods utilizes a proprietary fermentation process to create minimally processed steaks made from natural ingredients, ensuring its offerings are free from common allergens. The company markets its products online, making them accessible to a wide audience seeking vegan food choices that are both healthy and environmentally friendly.

Mindset Health

Seed Round in 2021
Mindset Health is a digital therapeutics company based in Melbourne, Victoria, founded in 2018 by Alex Naoumidis. The company focuses on helping individuals manage chronic health issues, particularly irritable bowel syndrome, anxiety, and chronic pain, through app-based hypnotherapy. Its platform provides treatment without necessitating dietary changes, enhancing sleep quality, and alleviating anxiety and stress. Mindset Health aims to offer a rapid, cost-effective, nonaddictive, and safe alternative for individuals seeking relief from these conditions, thereby improving overall well-being and quality of life.

BillionToOne

Series B in 2021
BillionToOne Inc. is a precision diagnostics company based in Menlo Park, California, that specializes in molecular testing for prenatal and oncology applications. Established in 2016, the company has developed a patented molecular counter platform capable of detecting and quantifying DNA molecules at an extraordinarily precise level. BillionToOne's flagship product, UNITY, is a noninvasive prenatal screening test that analyzes fetal cell-free DNA from a simple blood sample taken from the mother, allowing for the detection of single-gene disorders such as cystic fibrosis, spinal muscular atrophy, and beta-thalassemia. This innovative approach aims to replace more invasive procedures like amniocentesis, providing a safer and more affordable alternative for expecting mothers, particularly in developing countries. Additionally, the company is focused on oncology, offering tests that can accurately identify actionable mutations and assess tumor burden through blood samples.

Yuri

Seed Round in 2021
Yuri specializes in designing and manufacturing hardware for the aviation and aerospace industry, focusing on applications in microgravity research and experiments. The company provides an end-to-end space mission platform that includes services such as mission definition, hardware selection and development, as well as launch and return logistics. Additionally, Yuri supports researchers with a variety of advanced scientific services, including 3D cell culture growth, human disease modeling, protein and molecule analysis, synthetic biology, plant biology studies, and nanofluidics. This comprehensive approach enables researchers to access a quick and cost-effective combination of experimental hardware, facilities, and microgravity platforms.

MultiOmic Health

Pre Seed Round in 2021
MultiOmic Health is an AI-driven start-up specializing in drug discovery for metabolic syndrome-related diseases. The company collaborates with selected healthcare providers to collect and analyze de-identified patient data and bio-samples. Its MOHSAIC® platform integrates multi-omics analysis with computational systems biology modeling and targeted laboratory experiments to develop novel precision therapeutic concepts. These concepts are then commercialized through partnerships with established biopharma companies, facilitating the creation of new therapeutic and diagnostic research and development programs. By focusing on precision medicine, MultiOmic Health aims to improve treatment options for patients suffering from metabolic syndrome.

Gridware

Seed Round in 2021
Gridware specializes in advanced grid monitoring solutions aimed at enhancing the safety and reliability of electrical infrastructure. The company develops a sophisticated sensing system equipped with high-precision sensor arrays and artificial intelligence to continuously analyze the electrical and mechanical behavior of grid assets. This technology detects and predicts faults by monitoring the ambient environment around power poles, allowing utilities to identify potential issues before they escalate into serious problems. By facilitating timely repairs and enabling rapid responses to environmental anomalies, Gridware's solutions help mitigate risks such as wildfires and power outages. Headquartered in the Bay Area of California, Gridware is a privately held company supported by prominent climate-tech investors.

Multiply Labs

Series A in 2021
Multiply Labs specializes in the production of personalized pharmaceutical capsules that cater to the unique needs of individual patients. The company leverages a combination of pharmaceutical science and advanced robotics technology to create these tailor-made capsules. Its innovative approach includes operating a state-of-the-art robotic manufacturing facility, which allows for the efficient production of individualized drugs at a reduced cost. Multiply Labs stands out as a pioneer in the industry, being the first to introduce 3D printed capsules, thereby transforming how medications are customized to meet the specific metabolic requirements of patients.

Substack

Series B in 2021
Substack Inc. is an online platform that supports independent writers in creating and publishing both paid and free subscription newsletters. Established in 2017 and based in San Francisco, the platform provides tools for seamless web and newsletter publishing, allowing writers to reach their audiences via email and a dedicated website simultaneously. Substack's user-friendly editing software simplifies the publication process and includes features that help stories reach broader audiences beyond paywalls. Additionally, the platform facilitates payment management for subscriptions, enabling writers to generate income directly from their subscribers. This model empowers clients to establish and monetize their newsletter offerings effectively.

Faction

Seed Round in 2021
Faction develops software and services for driverless electric vehicles. Faction's supervised autonomous vehicle solutions include remote human TeleAssist® supervision, so we’re not gated by waiting for 100% autonomous technology. Initially, Faction is focusing on micro delivery for last mile logistics and vehicle-on-demand, where you can summon a vehicle and drive it yourself. The company has active customer programs in operation on public roads.

Noya

Seed Round in 2021
Noya is focused on addressing climate change by retrofitting existing industrial equipment to capture carbon dioxide from the atmosphere. The company's innovative technology utilizes a non-toxic chemical blend that is added to the cooling towers of various industries without requiring any structural modifications. This approach allows for effective CO2 capture while enabling businesses to contribute to environmental sustainability. By selling the captured carbon dioxide to companies that utilize it as a raw material, Noya facilitates a practical and scalable solution for reducing carbon emissions and promoting a transition towards a carbon-negative future.

Brave Care

Series A in 2021
Brave Care, Inc. specializes in urgent pediatric health care services, treating a wide range of conditions, including allergies, asthma, cough, ear pain, eye issues, fever, minor fractures, and rashes. The company also offers pediatric-specific laboratory services, on-site x-ray, and light sedation for certain procedures. Founded in 2019 and based in Portland, Oregon, Brave Care operates clinics exclusively designed for children in Oregon and Texas. In addition to in-person care, the BraveCare.com website and mobile app provide nationwide pediatric advice to assist parents in supporting their children's health and development.

WorkEQ

Pre Seed Round in 2020
WorkEQ is a business development and employment agency that focuses on enhancing workplace dynamics through flexible and productive work-life balance solutions. The company has developed a platform for contact tracing and health monitoring, designed to protect individuals from infectious diseases. This platform enables organizations to quickly access data on symptom onset and identify potentially exposed employees, facilitating timely responses to prevent viral outbreaks. By prioritizing health and safety, WorkEQ aims to improve employee engagement and productivity while fostering a more flexible and inclusive work environment.

Oolu

Series B in 2020
Oolu Inc. is a rapidly growing company specializing in solar home systems, providing installation, technical support, and maintenance services to households in West Africa, primarily from its base in Dakar, Senegal. With an additional office in San Francisco, the company aims to deliver affordable and reliable energy solutions to off-grid communities, particularly in rural and peri-urban areas. Oolu's solar home systems typically include adjustable lighting and USB charging capabilities, powered by batteries with a six-hour charge capacity. The company employs a monthly payment model to minimize financial barriers for customers, ensuring access to modern energy solutions while incorporating maintenance and battery replacement services. By fostering trust within local communities, Oolu strives to enhance energy access and improve the quality of life for its users.

Varda

Seed Round in 2020
Varda Space Industries, Inc. is a space manufacturing startup based in San Francisco, California, founded in 2020 by Delian Asparouhov and Trae Stephens. The company specializes in creating products in space that are intended for terrestrial applications, leveraging the unique advantages of low gravity. Varda aims to establish an infrastructure for harvesting materials from asteroids, enabling the production of new products in space. This approach not only facilitates the manufacturing of innovative goods but also promotes sustainability by reducing reliance on the destructive extraction of Earth's resources.

Kenota Health

Series A in 2020
Kenota Health specializes in the development of advanced diagnostic tools for allergy testing in humans. The company's innovative point-of-care system allows for the collection of small blood samples, which are analyzed using streamlined equipment to quickly determine allergen sensitization. This process delivers immediate test results, enabling physicians to obtain quality diagnostic information efficiently. By offering a safe, simple, and cost-effective alternative to traditional allergy testing methods, Kenota Health aims to enhance patient outcomes and streamline the diagnostic process in clinical settings.

Deepcell

Series A in 2020
Deepcell, Inc. is a biotechnology company based in Mountain View, California, that specializes in providing advanced diagnostic solutions through its innovative microfluidic imaging platform. Founded in 2015, the company focuses on delivering non-invasive tests with diagnostic-level accuracy, enabling researchers and clinicians to gain insights at the single-cell level. Deepcell's technology employs artificial intelligence to analyze and classify cells based on their morphological features, isolating viable cells for various applications in translational research, diagnostic testing, and therapeutics. By utilizing ordinary blood samples, Deepcell enhances the understanding of genetic health without the need for invasive procedures, thereby improving the diagnosis and treatment of diseases.

64x Bio

Seed Round in 2020
64x Bio develops a platform aimed at accelerating the discovery and optimization of mammalian cell lines for biomanufacturing and therapeutics. The company employs a high-throughput discovery and screening approach combined with an integrated computational design loop to create genetically engineered cell lines tailored for the production of viral vectors. This focus is particularly relevant for cell and gene therapies, as it enhances the efficiency of viral vector production. By providing purpose-built cell lines, 64x Bio enables pharmaceutical and biotechnology companies to improve their manufacturing capacity and reduce costs, ultimately facilitating the timely delivery of innovative therapies to patients.

Zero Acre Farms

Seed Round in 2020
Zero Acre Farms is a food company focused on eliminating the reliance on harmful vegetable oils in the food industry. It offers a sustainable alternative produced through fermentation technology, utilizing microorganisms to create oils and fats that contain significantly lower levels of unhealthy fats associated with inflammation and disease. This innovative approach aims to promote healthier dietary options for consumers while addressing the environmental concerns linked to traditional oil production.

Brightseed

Venture Round in 2020
Brightseed, Inc. is a biotechnology company based in San Francisco, California, that specializes in the discovery of bioactive compounds in plants to enhance human health. Utilizing its advanced Forager platform, which employs artificial intelligence and machine learning algorithms, Brightseed accelerates the identification and validation of clinically beneficial molecules. This innovative approach enables the company to uncover connections between natural compounds and health outcomes, revealing the potential of bioactives that have previously remained uncharted. By integrating these discoveries back into the food supply chain, Brightseed collaborates with various companies across the consumer health continuum to develop science-backed health solutions aimed at managing chronic diseases and improving overall quality of life. Founded in 2017, Brightseed is committed to exploring the untapped resources of the plant kingdom to address pressing health challenges.

Manifold Bio

Seed Round in 2020
Manifold Bio is a biotechnology company that features a platform that enables multiplexed quantitation of protein therapeutic designs, generating unprecedented data throughout the drug development process to unlock measurement-driven design. The company is building a protein barcoding platform to bring the power of multiplexed measurement to the development of protein therapeutics. It was founded in 2020 and headquartered in Boston, Massachusetts.

Ukama

Seed Round in 2020
Ukama offers the option to create custom LTE-based cellular networks to enterprises, ISPs, and individuals along with a modern stack.

Meati

Series A in 2020
Meati Foods is a Boulder, Colorado-based company specializing in the production and sale of fungi-based meat alternatives. Founded in 2016, the company aims to provide sustainable and nutritious plant-based options that serve as an alternative to traditional meat products. Meati Foods utilizes a proprietary fermentation process to create minimally processed steaks made from natural ingredients, ensuring its offerings are free from common allergens. The company markets its products online, making them accessible to a wide audience seeking vegan food choices that are both healthy and environmentally friendly.

Rad AI

Seed Round in 2020
Rad AI, Inc. is a company based in Berkeley, California, that specializes in developing an artificial intelligence platform designed to automate report generation for radiologists. Founded in 2018, Rad AI's solution streamlines the radiology workflow by automating repetitive tasks, thereby enhancing efficiency and accuracy while addressing issues of clinician burnout. The platform utilizes AI to generate report impressions, allowing radiologists to dictate findings using voice recognition technology, identify errors, and customize recommendations. By integrating smoothly with existing workflows, Rad AI aims to improve patient care and support radiologists in delivering accurate and timely reports.

Cover

Series A in 2020
Cover is a technology company that specializes in creating custom Backyard Studios and guesthouses as energy-efficient housing alternatives. The company employs proprietary design software to assess property specifications, facilitating a streamlined process that encompasses design, permitting, manufacturing, and installation. By utilizing a precision manufactured building system, Cover aims to deliver high-quality designs and functional spaces in significantly less time compared to traditional construction methods. Initially launched in Los Angeles, the company is now accepting pre-orders on a global scale, reflecting its commitment to making well-designed living spaces accessible to a broader audience.

Geltor

Series B in 2020
Geltor, Inc. is a biodesign company based in San Leandro, California, that specializes in producing bioactive, animal-free collagens and proteins for various applications in beauty, nutrition, and wellness. Established in 2015, Geltor offers innovative products such as Collume, which promotes skincare cellular regeneration and dermal synthesis, and HumaColl21, which enhances skin health by boosting collagen and elastin levels. Additionally, the company provides vegan collagen peptides and other novel proteins designed for functional food and nutraceutical formulations. Geltor's products are sustainably cultivated and clinically validated, allowing businesses to create effective, plant-based solutions that contribute to a more sustainable future.

Ansa Biotechnologies

Seed Round in 2020
Ansa Biotechnologies is manufactured via a chemical method that has remained essentially unchanged for 35 years and has approached a plateau. Ansa Biotechnologies is developing a novel DNA synthesis technology based on enzymes that will be more fast, accurate, and clean than existing methods. The technique promises to dramatically accelerate innovation in biological research and engineering.

Octant Bio

Series A in 2020
Octant Bio is a biotechnology company focused on developing synthetic technology aimed at enhancing health and treating diseases. The company employs a platform that integrates synthetic biology, genome engineering, next-generation sequencing, and computational tools to measure the activity of thousands of receptor pathways in human cells. This advanced technology allows scientists to utilize machine learning techniques to engineer small molecules capable of interacting with multiple receptors, thereby creating new possibilities for the treatment of complex diseases.

Manifold Bio

Pre Seed Round in 2020
Manifold Bio is a biotechnology company that features a platform that enables multiplexed quantitation of protein therapeutic designs, generating unprecedented data throughout the drug development process to unlock measurement-driven design. The company is building a protein barcoding platform to bring the power of multiplexed measurement to the development of protein therapeutics. It was founded in 2020 and headquartered in Boston, Massachusetts.

54gene

Series A in 2020
54gene is a healthcare company founded in 2019 by Dr. Abasi Ene-Obong, focused on advancing genomic research in Africa. Headquartered in San Francisco with an office in Lagos, Nigeria, the company aims to address the underrepresentation of African genetic data in pharmaceutical research, where only 2% of genetic material used is from African populations. By developing a pan-African biobank, 54gene seeks to identify new drug targets and create diagnostics and treatments for various diseases, including cancer, cardiovascular, and neurodegenerative diseases. Additionally, the company offers genetic testing and molecular diagnostics services to enhance understanding of the human genome and improve access to essential healthcare solutions.

Rebellyous Foods

Series A in 2020
Rebellyous Foods is a Seattle-based company founded in 2017 that specializes in producing plant-based meat alternatives, including chicken nuggets, patties, and strips. The company aims to make meat alternatives more accessible and affordable by implementing innovative food manufacturing technologies and processes designed for large-scale production. By utilizing high-throughput automation and energy-efficient manufacturing tools, Rebellyous Foods seeks to achieve price parity with traditional animal-based meats. Its products are primarily targeted at the food service market, including schools, hospitals, corporate cafeterias, and restaurants, providing customers with protein-rich options that can replace animal-based meat on a broad scale.

Solugen

Series B in 2020
Solugen, Inc. is a specialty chemicals company based in Houston, Texas, that focuses on producing industrial chemicals through industrial biotechnology and green chemistry. Founded in 2016, Solugen develops a range of environmentally friendly products, including BioPeroxide, a carbon-negative hydrogen peroxide, and BioChelate, a biodegradable chelant. The company also offers ScavSol, a multivalent metal sequestrant for energy applications; ScaleSol, an alternative to phosphonates for scale control; and CorrSol, a corrosion and fouling control product. By utilizing fermentation and enzymatic technology to convert plant sugars into chemicals, Solugen aims to replace petroleum-based products with plant-derived alternatives. Its innovative solutions are designed to benefit various industries, including agriculture, cleaning, energy, and water, while also addressing critical issues such as clean water, sustainable materials, and healthier personal care products.

Catalog

Series A in 2020
Catalog Technologies Inc. specializes in a DNA-based platform that revolutionizes digital data storage and computation. Founded in 2016 and headquartered in Boston, Massachusetts, the company provides a method for encoding digital information into DNA, making it a viable and cost-effective solution for long-term data archiving. By leveraging advanced synthetic biology technologies, Catalog aims to transform how information is stored, allowing customers to utilize DNA molecules as a primary medium for digital records. This innovative approach positions Catalog at the forefront of next-generation data storage solutions.

Microverse

Seed Round in 2020
Microverse is an online educational platform focused on training remote software developers. The organization aims to connect one million individuals with remote job opportunities by 2030. Its educational model emphasizes collaborative learning, where students from diverse backgrounds work in small, distributed teams and engage in pair programming. Through this approach, they hold each other accountable while developing their coding skills on open source and freelance projects. Microverse's programs are structured around income share agreements, allowing students to learn full-stack web development and receive career guidance. This model not only equips students with the necessary technical skills but also enables companies to recruit talented software developers without geographic limitations.

BillionToOne

Series A in 2020
BillionToOne Inc. is a precision diagnostics company based in Menlo Park, California, that specializes in molecular testing for prenatal and oncology applications. Established in 2016, the company has developed a patented molecular counter platform capable of detecting and quantifying DNA molecules at an extraordinarily precise level. BillionToOne's flagship product, UNITY, is a noninvasive prenatal screening test that analyzes fetal cell-free DNA from a simple blood sample taken from the mother, allowing for the detection of single-gene disorders such as cystic fibrosis, spinal muscular atrophy, and beta-thalassemia. This innovative approach aims to replace more invasive procedures like amniocentesis, providing a safer and more affordable alternative for expecting mothers, particularly in developing countries. Additionally, the company is focused on oncology, offering tests that can accurately identify actionable mutations and assess tumor burden through blood samples.

Astranis

Series B in 2020
Astranis is a satellite technology developer focused on providing high-speed internet access to underserved regions. The company aims to address the digital divide by launching satellites that can transmit data to specific terrestrial locations, facilitating internet connectivity for the estimated 4 billion people worldwide who currently lack access. By offering reliable internet services at significantly lower costs than traditional methods, Astranis enables governments and businesses to connect communities and expand internet access globally.

Advano

Series A in 2020
Advano, operating under NanoStar, Inc., is a New Orleans-based company founded in 2014 that specializes in silicon nanotechnology. The company focuses on the development and manufacturing of functionalized silicon nanoparticles, which serve as advanced anode materials for lithium-ion batteries. By integrating or replacing graphite with silicon, Advano enhances the energy density and longevity of batteries, making them suitable for electric vehicles, consumer electronics, and defense applications. Its innovative solutions aim to address the challenges of traditional battery technologies, providing scalable and cost-effective options that can easily integrate into existing lithium-ion battery infrastructure. Additionally, Advano's products are designed to support the energy transition and strengthen the domestic battery supply chain.

UPSIDE Foods

Series B in 2020
UPSIDE Foods, founded in 2015 and based in Berkeley, California, specializes in the production of cultivated meat derived directly from animal cells, eliminating the need to raise and slaughter animals. This innovative approach allows the company to offer real meat, poultry, and seafood while significantly reducing the resource consumption typically associated with conventional meat production, including water, land, and energy. UPSIDE Foods focuses on creating products such as beef meatballs, chicken, and duck, all grown in controlled environments. The company's mission is to provide consumers with clean, humane, and sustainable food options, free from harmful chemicals.

Arpeggio Bio

Seed Round in 2020
Arpeggio Biosciences leverages state of the art sequencing approaches coupled with powerful machine learning to uncover novel insights into a compound's biological mechanism of action. The company is diverse set of molecular biologists, computer scientists, and biotechnology enthusiasts passionate about understanding where, why, and how therapeutics work.

Farcast

Pre Seed Round in 2019
We build advanced satcom terminals

Antora Energy

Seed Round in 2019
Antora Energy specializes in providing zero-carbon industrial heat and power solutions for heavy industries, aiming to replace fossil fuels with cleaner alternatives. The company has developed innovative thermal batteries that utilize excess electricity generated from solar and wind sources. These batteries store thermal energy by heating blocks of carbon, which can then be used to produce reliable power and heat. By integrating renewable resources into the electricity grid, Antora enables industries to achieve sustainable and dependable energy solutions while significantly reducing carbon emissions.

Lively

Series B in 2019
Lively, Inc. is a health savings account (HSA) platform designed for both employers and individuals. Founded in 2016 and based in San Francisco, California, Lively offers a user-centric solution that enhances the experience of managing HSAs. The platform aims to help consumers optimize their healthcare spending, maximize savings, and improve their overall well-being. By providing an intuitive interface, Lively facilitates easier access to HSA-compatible plans, making healthcare management more straightforward for users.

Brave Care

Seed Round in 2019
Brave Care, Inc. specializes in urgent pediatric health care services, treating a wide range of conditions, including allergies, asthma, cough, ear pain, eye issues, fever, minor fractures, and rashes. The company also offers pediatric-specific laboratory services, on-site x-ray, and light sedation for certain procedures. Founded in 2019 and based in Portland, Oregon, Brave Care operates clinics exclusively designed for children in Oregon and Texas. In addition to in-person care, the BraveCare.com website and mobile app provide nationwide pediatric advice to assist parents in supporting their children's health and development.

Earth AI

Seed Round in 2019
Earth AI is a predictive explorer and driller specializing in critical minerals. The company operates as a vertically integrated mineral exploration firm, utilizing artificial intelligence to enhance mineral targeting. By predicting the locations of metallic ore bodies, Earth AI focuses on metals such as copper, lead, zinc, nickel, cobalt, vanadium, and rare earth elements. This innovative approach aims to improve the success rates of mineral discoveries while simultaneously reducing operational risks and costs for mining explorers.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.